Daniel Lynch, Director at bluebird bio, Inc. (BLUE), sold 150 shares at $80.22 ($12K) on 2017-02-15, disclosed to the SEC on 2017-02-17.
Scheduled sale ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SWTX | SELL | 2025-02-12 | $15.4M | — | Filing → |
| BPMC | SELL | 2018-02-16 | $1.0M | — | Filing → |
| BPMC | SELL | 2018-02-14 | $2.6M | — | Filing → |